THE RATE OF RENAL DYSFUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER USING X-RAY CONTRAST AGENTS
https://doi.org/10.21886/2219-8075-2015-3-32-36
Abstract
Purpose: to evaluate the rate and severity of filtration renal dysfunction in patients with acute coronary syndrome after percutaneous coronary intervention (PCI) with X-ray contrast.
Materials and Methods: serum creatinine levels were collected from 71 patients twice, before the introduction of the contrast agent and 3 days.
Resuls: in 56.9% of cases was recorded worsening renal function, and in 37.3% diagnosed the incidence of contrast-induced nephropathy (CIN), defined as a rise in serum creatinine level by 25% or more.
Summary: because at the time of admission to the hospital, a physician still does not have enough reliable criteria for evaluating the risk of CIN, a preventive measures for improving renal function have to be included in the complex treatment of patients who are receiving the radiocontrast agent. Regardless of the severity of patients’ condition and the presence of concomitant chronic diseases.
About the Authors
N. T. VatutinRussian Federation
Department of Internal Medicine № 1
M. I. Zinkovych
Russian Federation
References
1. Caruso M. Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized / M. Caruso, F. Balasus, E. Incalcaterra, A. Ruggier, S. Evola, K. Fattouch, U.M. Bracale, E. Amodio, G. Novo, G. Andolina, S. Novo // Intern. Med.- 2011.- V. 50, № 9.- p. 983-989.
2. McCullough P.A. Contrast-induced acute kidney injury / P.A. McCullough // J. Am. Coll. Cardiol.- 2008.- V. 51, № 15.- p. 1419-1428.
3. Sterenborg T.B. Remote ischemic preconditioning to reduce contrast-induced nephropathy: study protocol for a randomized controlled trial / T.B. Sterenborg, T.P. Menting, R. Donders, K.E. Wever, M.S. Lemson, D.J. Vliet, J.F. Wetzels, L.J. Schultze, M.C. Warle // Trials.- 2014.- V. 15.- p. 119.
4. Волгина Г.В. Контраст-индуцированная нефропатия: патогенез, факторы риска, стратегия профилактики (Часть I) / Г.В. Волгина // Нефрология и диализ.- 2006.- V. 8, № 1.- c. 69-77.
5. Mehran R. Contrast-induced nephropathy: definition, epidemiology, and patients at risk / R. Mehran, E. Nikolsky //
6. Kidney Int. Suppl.- 2006.- № 100.- p. S11-S15.
7. Ватутин Н.Т. Реперфузионное повреждение миокарда / Н.Т. Ватутин, Н.В. Калинкина, Е.В. Ещенко, И.Н. Кравченко // Кардіохірургія та інтервенційна кардіологія.- 2013.- № 1.-c. 15-22.
8. Fassett R.G. Biomarkers in chronic kidney disease: a review / R.G. Fassett, S.K. Venuthurupalli, G.C. Gobe, J.S. Coombes, M.A. Cooper, W.E. Hoy // Kidney Int.- 2011.- V. 80, № 8.-p. 806-821.
9. Левицкая Е.С. Оценка влияния почечных факторов риска и параметров коронарной атеросклеротической бляшки на вероятность развития рецидива стенокардии у больных, подвергшихся реваскуляризации миокарда / Е.С. Левицкая, М.М. Батюшин, В.П. Терентьев, А.А. Дюжиков, А.В. Хрипун // Клиническая нефрология.- 2012.- № 3.- c. 30-33.
10. Батюшин М.М., Врублевская Н.С. Клинические проявления поражения почек при хронической сердечной недостаточности / М.М. Батюшин, Н.С. Врублевская // Нефрология.- 2010.- T. 14, № 4.- c. 27-30.
Review
For citations:
Vatutin N.T., Zinkovych M.I. THE RATE OF RENAL DYSFUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME AFTER USING X-RAY CONTRAST AGENTS. Medical Herald of the South of Russia. 2015;(3):32-36. (In Russ.) https://doi.org/10.21886/2219-8075-2015-3-32-36